CLINICAL_TRIALS
trial_result
· 2023-12-14
Clinical Trial Update: Long-term Study of SYR-472 [Phase 3]
Summary
A long-term Phase 3 clinical trial update for SYR-472 in diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED